Takeda Turnaround In Full Flow As New Products Deliver
This article was originally published in PharmAsia News
Takeda has closed out its "turnaround year" on target, meeting guidance for fiscal 2015. The company has been undergoing a reorganization to pull it through intense generic competition and CEO Christophe Weber took the year-end opportunity to outline how the strategy was playing out for the Japanese pharma, and also to stress its continued commitment to the ‘up and down’ emerging markets.
Register for our free email digests: